Search

Your search keyword '"Rasagiline -- Reports"' showing total 9 results
Start Over Descriptor "Rasagiline -- Reports" Publisher normans media ltd.
9 results on '"Rasagiline -- Reports"'

1. Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma

Subjects
Innoviva Inc. -- Reports -- Growth, H. Lundbeck A/S -- Reports -- Growth, Biological products industry -- Industry forecasts, BCG vaccines -- Growth -- Reports, Atrophy -- Reports, BCG -- Growth -- Reports, Rasagiline -- Reports, Biotechnology industry -- Industry forecasts, Epidemiology -- Reports, Pharmaceutical industry -- Industry forecasts, Company growth, Business, Business, international
Abstract

M2 PRESSWIRE-November 20, 2024-: Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma (C)1994-2024 M2 [...]

Published
2024

2. Parkinson's Disease Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, Pipeline, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Rotigotine, LY03003, LY3884961, More

Subjects
AstraZeneca PLC -- Product development, Business -- Research, Rasagiline -- Reports, Diseases -- United Kingdom, Pramipexole -- Product development, Drug approval -- Reports, Clinical trials -- Reports, Pharmaceutical industry -- Product development, Exenatide -- Product development, Business, Business, international
Abstract

M2 PRESSWIRE-June 3, 2024-: Parkinson's Disease Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, Pipeline, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Rotigotine, LY03003, LY3884961, More (C)1994-2024 [...]

Published
2024

3. Restkess Leg Syndrome Pipeline | Clinical Trials , Key Companies

Subjects
Business -- Research, Rasagiline -- Reports, Clinical trials -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-November 8, 2023-: Restkess Leg Syndrome Pipeline | Clinical Trials , Key Companies (C)1994-2023 M2 COMMUNICATIONS RDATE:07112023 Restless Leg Syndrome Pipeline Insight, 2023' report by DelveInsight outlays comprehensive insights [...]

Published
2023

4. Parkinson's Disease Clinical Trials and Therapies 2023: Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight | Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca

Subjects
AstraZeneca PLC -- Reports, Business -- Research, Rasagiline -- Reports, Pramipexole -- Reports, Pharmaceutical industry -- Reports, Exenatide -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-April 19, 2023-: Parkinson's Disease Clinical Trials and Therapies 2023: Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight | Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca (C)1994-2023 M2 COMMUNICATIONS [...]

Published
2023

5. Parkinson's Disease Drugs Pipeline 2023: Clinical Trials, Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight |Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca

Subjects
AstraZeneca PLC -- Reports, Business -- Research, Rasagiline -- Reports, Pramipexole -- Reports, Pharmaceutical industry -- Reports, Exenatide -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-April 10, 2023-: Parkinson's Disease Drugs Pipeline 2023: Clinical Trials, Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight |Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca (C)1994-2023 M2 COMMUNICATIONS RDATE:06042023 [...]

Published
2023

6. 140+ Active Companies working to Develop 150+ Pipeline Therapies for Parkinson's Disease Treatment

Subjects
Rasagiline -- Reports, Pramipexole -- Reports, Exenatide -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-March 24, 2023-: 140+ Active Companies working to Develop 150+ Pipeline Therapies for Parkinson's Disease Treatment (C)1994-2023 M2 COMMUNICATIONS RDATE:23032023 DelveInsight's, 'Parkinson's Disease Pipeline Insight 2023' report provides comprehensive [...]

Published
2023

7. Parkinson's Disease Pipeline Insights and Clinical Trials 2023 | DelveInsight

Subjects
Business -- Research, Rasagiline -- Reports, Pramipexole -- Reports, Clinical trials -- Reports, Exenatide -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-January 16, 2023-: Parkinson's Disease Pipeline Insights and Clinical Trials 2023 | DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:13012023 DelveInsight's, 'Parkinson's Disease Pipeline Insight, 2023,' report provides comprehensive insights about 140+ [...]

Published
2023

8. Parkinson's Disease Pipeline Analysis: 140+ Companies are Working to Improve the Treatment Space | DelveInsight

Subjects
Business -- Research, Rasagiline -- Reports, Pramipexole -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-November 8, 2022-: Parkinson's Disease Pipeline Analysis: 140+ Companies are Working to Improve the Treatment Space | DelveInsight (C)1994-2022 M2 COMMUNICATIONS RDATE:07112022 DelveInsight's, 'Parkinson's Disease Pipeline Insight, 2022,' report [...]

Published
2022

9. Monoamine Oxidase Inhibitors Pipeline Insight Report 2021

Subjects
Methylene blue -- Reports, Homeopathy -- Materia medica and therapeutics, Rasagiline -- Reports, Therapeutics -- Reports, Oxidases -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-July 5, 2021-: Monoamine Oxidase Inhibitors Pipeline Insight Report 2021 (C)1994-2021 M2 COMMUNICATIONS RDATE:05072021 The 'Monoamine Oxidase Inhibitors - Pipeline Insight, 2021' drug pipelines has been added to ResearchAndMarkets.com's [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results